Rufen Sie uns an
(0211) 65 85 19 0
Aktuelles

Aktuelles

Wollen Sie mehr wissen?

BioLinX Success Story | Training and support in acquiring private financing

- Kategorie: EU-Förderung, Forschung und Entwicklung, Umwelt und Energie

01.09.2017

BioLinX  Success Story | Training and support in acquiring private financing


Are you looking for private financing? BioLinX offers assistance in finding it. We can help you to get investment-ready and can provide advice, training and access to private funding. We already helped out various parties.

For example:

The owner of a company in the Southwest Netherlands, supplying cost effective plants and equipment to enable the production of high-quality, biobased particleboard panels in commercial quantities. The technology involved an ecologically sound bonding system, thereby eliminating the harmful formaldehyde emissions.

The main challenge for this company, in this stage, was to find investors. This had proven to be a difficult path.

This company was invited to attend a ‘BioLinX Finance Academy’. Part of this event was an in-depth training on managing IP (intellectual Property). This turned out to be highly valuable. In the entrepreneurs own words: “The IP information was really an eye-opener. It showed me the direction to a new way of doing business: based on royalties. I had never realized that my trademark is such an important asset!”

This BioLinX relation has since changed the course of his company. Now he is more interested in marketing the brand, and not so much in developing one factory after another. The new course helps him to focus on quality and certifications, thereby increasing the brand value.

As a perspective, there is a large market for high-quality biobased eco-materials, but potential customers require some sort of guarantee that the materials they buy are indeed what the suppliers says they are. A trademark is such a guarantee.

This, using IP in a smart way, is potentially a means for European companies to compete with cost competitors from for instance China.

Contact our BioLinX-Experts for more information.

Wollen Sie mehr wissen?